S-217622 clinical trials

A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Shionogi Protease Inhibitor (S-217622)

This study is looking into a new medication called S-217622 for people in hospital with COVID-19. It aims to see if the medication is safe and helps people recover faster. They will compare it to a dummy treatment.